FindTrial
Sign In

To know the effect of Individualized Homoeopathic medicines as a supportive Treatment in the improvement of Dementia in old age group

Effectiveness of Individualized Homoeopathic Medicines as an Adjuvant Treatment in the Management of Dementia in Geriatric Age Group- Single Blind Randomized Prallel Arm Experimental Controlled Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101858
Enrollment
96
Registered
2026-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F028- Dementia in other diseases classified elsewhere Health Condition 2: F039- Unspecified dementia Health Condition 3: F015- Vascular dementia

Interventions

Intervention1: Individualized homoeopathic medicines: Dose of individualized homoeopathic medicines with indicated potency based on susceptibility and frequency of dose would be given once in a month

Sponsors

Hamsa Homeopathy Medical College, Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: cases belonging to all genders cases of age group above 65 years cases undergoing regular allopathic treatment for dementia cases with or without co-morbities will be included

Exclusion criteria

Exclusion criteria: cases suffering from other psychiatric illness cases suffering from dementia due to head injury cases that are physically disabled cases that are mentally retarded cases who are suffering from carcinoma cases of CKD who are on dialysis cases undergoing treatment other than allopathic

Design outcomes

Primary

MeasureTime frame
Individualized homoeopathic meedicines are effective as ab adjuvant treatment in the management of dementia in geriatric age groupTimepoint: Individualized homoeopathic meedicines are effective as ab adjuvant treatment in the management of dementia in geriatric age group—

Secondary

MeasureTime frame
To evaluate the effect of individualized homoempathic medicines as an adjuvant treatment on the cognitive function in geriatric patients with dementia using MoCA scale up to 12 months compared to control groupTimepoint: MoCA scale applied at baseline, 6 and 12 months;To evaluate the effect of Individualized homoeopathic medicines as an adjuvant treatment on the quality of life in geriatric patients with dementia using DemQOL scaleTimepoint: DemQOL scale applied at baseline, 6 and 12 months;To fins out indicated remedies for dementia in geriatric age groupTimepoint:—

Countries

India

Contacts

Public ContactDr Shwetal K

Dr G D Pol Foundation YMT Homoeopathic Medical College and Hospital (Post graduate Institute)

newbeginingsach@yahoo.com9172488888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026